Navigation Links
Novartis Phase III Study Shows ACZ885 Helped Substantially Reduce Steroid Use in 45% of Patients With Serious Form of Childhood Arthritis
Date:11/6/2011

.

"These data demonstrate the significant benefits that ACZ885 may provide this young population, both in steroid reduction and in extending the period these children can live free from SJIA flares," said David Epstein, Head of the Pharmaceuticals Division of Novartis. "Novartis is committed to helping improve the health of patients with SJIA and other inflammatory diseases, which is why we are delighted to be sharing these results."

ACZ885 is an investigational fully human monoclonal antibody which neutralizes the key inflammatory mediator, interleukin-1 beta (IL-1 beta), which plays an important role in a number of diseases including SJIA[5].

The incidence of SJIA is estimated to be less than 1 in 100,000 children[6]. It is called 'systemic' because the inflammation affects the whole body, as well as most of the joints[4]. The condition is characterized by potentially life-long, recurrent and painful arthritis flares, skin rashes and daily spiking fevers[2],[4].

Novartis is also presenting a number of other studies at ACR, including a second pivotal Phase III trial of ACZ885 in SJIA, which was previously presented at the 2011 European Pediatric Rheumatology Congress in Bruges, Belgium, in September.

About the StudyThe Phase III, two-part study had an open-label, single-arm active treatment in Part I followed by a randomized, double-blind, placebo-controlled, event-driven withdrawal design in Part II[1]. A total of 177 patients between the ages of 1 and 19 years with active SJIA were enrolled in the study[1]. In Part I, patients received a subcutaneous (s.c.) dose of ACZ885 (4 mg/kg, up to 300 mg) every 4 weeks. After 8 weeks, patients who met the adapted ACR Pediatric 30 criteria began tapering (reducing) their steroid use until either: a) the dose had been decreased to less than or equal to 0.5 mg/kg[7] while maintaining the adapted ACR Pediatric 30 Criteria (successful tapering of steroids); or b)
'/>"/>

SOURCE Novartis
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Cequent Pharmaceuticals Meets Novartis Option Fund Milestone; Continues to Next Phase to Validate Inflammatory Bowel Disease Targets in Vivo
2. Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe
3. Nektar Sells Pulmonary Business to Novartis For $115 Million and Nektar Retains Key Pulmonary Programs Including Amikacin Inhale, Inhaled Vancomycin, and Ciprofloxacin Inhalation Powder
4. Nektar Announces Closing of Sale of Specific Pulmonary Delivery Assets to Novartis for $115 Million
5. Physicians in Europe Rate Novartis #1 on Service Delivery, While Merck Earns Top Honors in the US
6. Novartis/Schering-Ploughs Drug Will Replace AstraZenecas Symbicort as Decision Resources Clinical Gold Standard by 2012 for the Treatment of Asthma
7. Schering-Plough Announces Changes to its Global Collaboration with Novartis to Develop Combination Therapies for Asthma and COPD
8. Photo: Novartis Receives FDA Approval for Valturna(R), a Single-Pill Combination of valsartan and aliskiren, to Treat High Blood Pressure
9. Heptares Therapeutics Announces Agreement With Novartis Option Fund to Apply its StaR(TM) Technology and Generate Novel Drug Leads Against a GPCR Target
10. Novartis Class Awarded $250 Million in Punitive Damages
11. Silence Therapeutics Partner Quark Signs Exclusive Option Agreement With Novartis for Development and Commercialisation of QPI-1002
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... June 18, 2013 Kitware , ... announces a new Fast-Track award from the U.S. Department ... environment (IDAE) for the nuclear power industry. , Construction ... more than 30 years, but the United States’ nuclear ... gains in power plant utilization through improved refueling, maintenance, ...
(Date:6/17/2013)... Belvoir, VA (PRWEB) June 17, 2013 ... annual Basic Research Technical Review at the Waterford in ... More than 300 grant awardees will present technical details ... Technical sessions will cover a broad range of counter ... (2) Cognitive, Information and Network Science; (3) Science for ...
(Date:6/17/2013)... (PRWEB) June 17, 2013 With the huge ... launch of the Chief Medical Officer Summit for Emerging Life ... will take place in San Francisco on November 4-5, 2013 ... the first time, West Coast Chief Medical Officers at biotechs ... Elizabeth Stoner, Managing Director of MPM Capital. Valerie Bowling, Executive ...
(Date:6/17/2013)... June 17, 2013 ... announced the addition of the "North ... Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables ... Free & Auto Injectors] & Therapeutics- Forecasts ... ,      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ...
Breaking Biology Technology:Kitware to Develop an Open-Source HPC Design-Analysis Environment for Nuclear Energy Research 2Invitation to Register: Annual Defense Threat Reduction Agency Basic Research Technical Review 2Chief Medical Officer Summit for Biotechs Goes West 2Chief Medical Officer Summit for Biotechs Goes West 3North America Injectable Drug Delivery Market - by Formulations, Devices & Therapeutics- Forecasts to 2017 2North America Injectable Drug Delivery Market - by Formulations, Devices & Therapeutics- Forecasts to 2017 3
... , , ... , , , ... analysis.,By comparing the separated bands,of an unknown sample to a ... fragment,can be estimated. The Agilent,2100 bioanalyzer is an instrument,which utilizes ...
... , , ... , , , Whereas in ... molecules, the development of soft ionization methods,such as matrix-assisted laser desorption/ionization ... the analysis of proteins up to 300 kDa using MS has,become ...
... , , , ... , , , , ... studying functional,assays requiring the transfection of small interfering RNA (siRNA),into a cell, ... given cell lines would be of great value.,Three to four siRNA sequences ...
Cached Biology Technology:High resolution DNA analysis with the,DNA 500 and DNA 1000 LabChip kits 2High resolution DNA analysis with the,DNA 500 and DNA 1000 LabChip kits 3High resolution DNA analysis with the,DNA 500 and DNA 1000 LabChip kits 4High resolution DNA analysis with the,DNA 500 and DNA 1000 LabChip kits 5Using the Agilent 2100 bioanalyzer for,quality control of protein samples prior to,MS-analysis 2Using the Agilent 2100 bioanalyzer for,quality control of protein samples prior to,MS-analysis 3Using the Agilent 2100 bioanalyzer for,quality control of protein samples prior to,MS-analysis 4Using the Agilent 2100 bioanalyzer for,quality control of protein samples prior to,MS-analysis 5siRNA transfection optimization,with the Agilent 2100 bioanalyzer 2siRNA transfection optimization,with the Agilent 2100 bioanalyzer 3siRNA transfection optimization,with the Agilent 2100 bioanalyzer 4siRNA transfection optimization,with the Agilent 2100 bioanalyzer 5siRNA transfection optimization,with the Agilent 2100 bioanalyzer 6siRNA transfection optimization,with the Agilent 2100 bioanalyzer 7
(Date:6/17/2013)... Patients in Vietnam and other locations with central nervous ... of a newly discovered virus, according to a study ... open-access journal of the American Society for Microbiology. Researchers ... percent of 642 patients with central nervous system infections ... percent of fecal samples from pigs and poultry, suggesting ...
(Date:6/17/2013)... kids eat their food may turn out to be just ... study out of St. Michael,s Hospital. , The study, ... significant association between poor eating habits in kids ages ... "bad" cholesterol, putting them at risk for cardiovascular disease ... Canadian Medical Association Journal today. , "We ...
(Date:6/17/2013)... of improving original foundations with more modern elements. Using ... Pittsburgh,s Kenneth P. Dietrich School of Arts and Sciences ... drug delivery, gas storage, and gas transport more efficient ... in the latest issue of the Journal of ... The recent work builds upon Pitt Associate Professor of ...
Breaking Biology News(10 mins):New virus discovered in patients with central nervous system infections 2New virus discovered in patients with central nervous system infections 3Poor eating behaviors may put preschoolers at risk for later health problems 2'Chemical architects' build materials with potential applications in drug delivery and gas storage 2
... circles that rural peasant activities are at odds ... In fact, the opposite is often true, argue ... Perfecto. , Combining case studies with ecological ... farming practices encouraged by grassroots movements such as ...
... mechanism that regulates how many new cells are produced ... in the latest issue of the prestigious scientific journal, ... for things like neurological disorders and anaemia," says Professor ... old cells are continually being replaced by new. If ...
... reaching age 90 with preserved cognition, according to a ... Journal of Geriatric Psychiatry. The study, which was conducted ... to identify genetic links to cognitive longevity. , "Successful ... focused on individuals who had reached at least 90 ...
Cached Biology News:Agriculture and tropical conservation: rethinking old ideas 2Agriculture and tropical conservation: rethinking old ideas 3New stem-cell findings can help the body to cure itself 2New research examines genetics of successful aging 2
ANTI L-DOPA...
The Light Diagnostics Calicivirus Genotype 1&2 Typing OligoDetect assay is applicable for the qualitative detection of calicivirus RNA generated by an in-house validated in vitro nucleic acid amplifi...
Recombinant Rat CINC-2 alpha, CF...
sodium channel, nonvoltage-gated 1 alpha,...
Biology Products: